Seroatlas · Human Serome Atlas

ENO1

Alpha-enolase

Also known as: ENO1L1, ENOA_HUMAN, MBP-1, MPB1, PPH

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
P06733
Gene
ENO1
Ensembl
ENSG00000074800
Chromosome
1
Canonical length
434 aa
Protein class
Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins
Subcellular location
Plasma membrane,Cytosol
Quaternary structure
Homodimer

OverviewNCBI Gene

This gene encodes alpha-enolase, one of three enolase isoenzymes found in mammals. Each isoenzyme is a homodimer composed of 2 alpha, 2 gamma, or 2 beta subunits, and functions as a glycolytic enzyme. Alpha-enolase in addition, functions as a structural lens protein (tau-crystallin) in the monomeric form. Alternative splicing of this gene results in a shorter isoform that has been shown to bind to the c-myc promoter and function as a tumor suppressor. Several pseudogenes have been identified, including one on the long arm of chromosome 1. Alpha-enolase has also been identified as an autoantigen in Hashimoto encephalopathy. [provided by RefSeq, Jan 2011]

Canonical amino-acid sequenceUniProt

434 residues, UniProt reviewed canonical sequence.

>P06733|ENO1
     1  MSILKIHARE IFDSRGNPTV EVDLFTSKGL FRAAVPSGAS TGIYEALELR DNDKTRYMGK
    61  GVSKAVEHIN KTIAPALVSK KLNVTEQEKI DKLMIEMDGT ENKSKFGANA ILGVSLAVCK
   121  AGAVEKGVPL YRHIADLAGN SEVILPVPAF NVINGGSHAG NKLAMQEFMI LPVGAANFRE
   181  AMRIGAEVYH NLKNVIKEKY GKDATNVGDE GGFAPNILEN KEGLELLKTA IGKAGYTDKV
   241  VIGMDVAASE FFRSGKYDLD FKSPDDPSRY ISPDQLADLY KSFIKDYPVV SIEDPFDQDD
   301  WGAWQKFTAS AGIQVVGDDL TVTNPKRIAK AVNEKSCNCL LLKVNQIGSV TESLQACKLA
   361  QANGWGVMVS HRSGETEDTF IADLVVGLCT GQIKTGAPCR SERLAKYNQL LRIEEELGSK
   421  AKFAGRNFRN PLAK

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against ENO1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.19
Highest tissue expression
1,003 nTPM

Expression across tissuesHPA

Tissue

  • esophagus: 1,003 nTPM
  • kidney: 950 nTPM
  • choroid plexus: 840 nTPM
  • basal ganglia: 794 nTPM
  • bone marrow: 749 nTPM
  • cerebral cortex: 746 nTPM

Single-cell type

  • esophageal basal cells: 2,586 nCPM
  • extravillous trophoblasts: 2,439 nCPM
  • esophageal suprabasal cells: 2,329 nCPM
  • müller glia: 2,323 nCPM
  • esophageal apical cells: 2,123 nCPM
  • migrating cytotrophoblasts: 2,045 nCPM

Immune cell

  • total PBMC: 2,170 nTPM
  • myeloid DC: 1,217 nTPM
  • classical monocyte: 1,200 nTPM
  • non-classical monocyte: 834 nTPM
  • intermediate monocyte: 823 nTPM
  • T-reg: 702 nTPM

Brain region

  • cerebellum: 692 nTPM
  • hippocampal formation: 599 nTPM
  • medulla oblongata: 573 nTPM
  • midbrain: 552 nTPM
  • pons: 536 nTPM
  • hypothalamus: 524 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about ENO1.

Disease | ImmuneIEDB

Conditions an epitope on ENO1 was assayed in.

Disease | AutoantibodyPubMed

Conditions in which antibodies against ENO1 are reported. Each links to that disease's full target list.

Showing 13 of 14 — disease pages carrying at least 10 antigens.

ReferencesPubMed · IEDB

Publications for ENO1 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.

Reference: AutoantibodyPubMed

92 publications

Show 20 more of 92 total

Reference: B cellIEDB

36 publications

Show 20 more of 36 total

Reference: T cellIEDB

10 publications

Show 5 more

Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.86
gnomAD pLI
0
gnomAD missense Z
0.84
DepMap mean gene effect
-0.38
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of ENO1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads ENO1 as an antibody target. Whether an autoantibody or antibody against ENO1 could matter depends on whether native ENO1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

ENO1 is annotated at the cell surface, where native ENO1 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Source-annotated serology context

The source annotations explicitly mention antibody, autoantibody, autoantigen, or autoimmune context. This is biological context, not study-specific reactivity.

  • Alpha-enolase has also been identified as an autoantigen in Hashimoto encephalopathy.

Canonical record: https://seroatlas.com/gene/ENO1. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...